COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,164 Articles (22,703 medRxiv, 8,461 bioRxiv)

Most recent first Previous |  Page 1003: Articles 10021-10030  | Next

The impact of demographic factors on numbers of COVID-19 cases and deaths in Europe and the regions of Ukraine
Nesteruk, I., Rodionov, O.
10.1101/2022.01.05.22268787 — Posted: 2022-01-06
Vaccinating children against COVID-19: commentary and mathematical modelling
Hawkes, M. T., Good, M. F.
10.1101/2022.01.05.22268820 — Posted: 2022-01-06
Protection afforded by prior infection against SARS-CoV-2 reinfection with the Omicron variant
Altarawneh, H., Chemaitelly, H., Tang, P., Hasan, M. R., Qassim, S., Ayoub, H. H., AlMukdad, S., YASSINE, H. M., Benslimane, F., Al Khatib, H. A., Coyle, P., Al Kanaani, Z., Al Kuwari, E., Jeremijenko, A., Kaleeckal, A. H., Latif, A. N., Shaik, R. M., Abdul Rahim, H. F., Nasrallah, G., Al Kuwari, M. G., Butt, A. A., Al Romaihi, H. E., Al-Thani, M. H., Al Khal, A., Bertollini, R., Abu-Raddad, L. J.
10.1101/2022.01.05.22268782 — Posted: 2022-01-06 Discussion: Onsite
A Composite Ranking of Risk Factors for COVID-19 Time-To-Event Data from a Turkish Cohort
Ulgen, A., Cetin, S., Cetin, M., Sivgin, H., LI, W.
10.1101/2022.01.05.22268765 — Posted: 2022-01-06
Regulatory T-cells are central hubs for age-, sex- and severity-associated cellular networks during COVID-19
Sondergaard, J., Tulyeu, J., Edahiro, R., Shira, Y., Yamaguchi, Y., Murakami, T., Morita, T., Kato, Y., Hirata, H., Takeda, Y., Okuzaki, D., Sakaguchi, S., Kumanogoh, A., Okada, Y., Wing, J.
10.1101/2022.01.06.22268711 — Posted: 2022-01-06
Lineage replacement and evolution captured by the United Kingdom Covid Infection Survey
Lythgoe, K. A., Golubchik, T., Hall, M., House, T., MacIntyre-Cockett, G., Fryer, H., Thomson, L., Nurtay, A., Buck, D., Green, A., Trebes, A., Piazza, P., Lonie, L. J., Studley, R., Rourke, E., Cook, D., Smith, D., Bashton, M., Nelson, A., Crown, M., McCann, C., Young, G. R., de Santos, R. A. N., Richards, Z., Tariq, A., Wellcome Sanger Institute COVID-19 Surveillance Team, , COVID-19 Infection Survey Group, , The COVID-19 Genomics UK (COG-UK) consortium, , Fraser, C., Diamond, I., Barrett, J., Walker, S., Bonsall, D.
10.1101/2022.01.05.21268323 — Posted: 2022-01-06
Cell-mediated and humoral immune response to SARS-CoV-2 vaccination and booster dose in immunosuppressed patients
Yang, L. M., Costales, C., Ramanathan, M., Bulterys, P. L., Murugesan, K., Schroers-Martin, J., Alizadeh, A. A., Boyd, S. D., Brown, J. M., Nadeau, K. C., Nadimpalli, S. S., Wang, A. X., Busque, S., Pinsky, B. A., Banaei, N.
10.1101/2022.01.04.22268750 — Posted: 2022-01-05
Narrowing gap in regional and age-specific excess mortality in the first year and a half of COVID-19 in Hungary
Toth, C. G.
10.1101/2022.01.05.22268786 — Posted: 2022-01-05
Sub-optimal Neutralisation of Omicron (B.1.1.529) Variant by Antibodies induced by Vaccine alone or SARS-CoV-2 Infection plus Vaccine (Hybrid Immunity) post 6-months
Medigeshi, G. R., Batra, G., Murugesan, D. R., Thiruvengadam, R., Chattopadhyay, S., Das, B., Gosain, M., Ayushi, , Singh, J., Anbalagan, A., Shaman, H., Pargai, K., Mehdi, F., Das, S. J., Kahlon, N., Singh, S., Kshetrapal, P., Wadhwa, N., Pandey, A. K., Bhatnagar, S., Garg, P. K.
10.1101/2022.01.04.22268747 — Posted: 2022-01-05
Timing of Breakthrough Infection Risk After Vaccination Against SARS-CoV-2
Tuite, A., Lee, N., Fisman, D.
10.1101/2022.01.04.22268773 — Posted: 2022-01-05

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).